Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COnCERTO: Neoadjuvant Chemotherapy for Obstructive Colon Cancer
NCT06107920Phase 3Recruiting
- Sponsor
- Rouen University Hospital
- Start
- May 2024
- Primary completion
- Aug 2031
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of FOLFOX, Capecitabine + oxaliplatin in colon cancer, sponsored by Rouen University Hospital. Started May 2024; status: recruiting.
02
Drugs
FOLFOXCapecitabine + oxaliplatin
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT06107920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06107920.